Blogroll
Link
- Argentinean Network of Women Living with HIV-AIDS
- Asia Pacific Network of People Living with HIV/AIDS
- bilaterals.org
- Cambodian People Living with HIV/AIDS Network (CPN+)
- Delhi Network of Positive People (DNP+)
- Essentialdrugs.org
- FACEBOOK PAGE: Stop the EU India Free Trade Agreement
- FTA Malaysia
- Health Action International – Asia Pacific
- Intellectual Property Watch
- Lawyers Collective HIV/AIDS Unit
- MSF Access Campaign
- National Association of People Living with HIV and AIDS in Nepal (NAPN)
- Patent Opposition Database
- Public Citizen
- Stop Peru FTA
- Thai Network of People Living with HIV/Aids (TNP+)
- Third World Network
Take Action
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
-
Recent Posts
- Live from the Trans Pacific Partnership: IP Chapter Shows No Sign of Resolution, End of Negotiation in 2013 Highly Unlikely
- TRIPS Exemption Opposed By Obama Administration, Threatening Cost Spike For Drugs In Poorest Nations
- Open Letter to TRIPS Council Chairman on LDC Extension: Alfredo Suescum, Ambassador of Panama to the World Trade Organization (WTO)
- Trans Pacific Partnership Negotiations and the Controversial Issue of Pharmaceutical Test Data Protection
- India-EU FTA talks fail to bridge gaps; ministerial meet unlikely
Categories
Monthly Archives: May 2011
Briefing Paper: Investment and IPR chapters of EU India FTA endangers access to medicines
A brief analysis of investment and IPR chapter of EU- India FTA is released by civil society and community networks highlighting the threat to access to medicines in India and the developing world. The briefing paper provides in-depth analysis of … Continue reading
Posted in data exclusivity, EU-India FTA, IPR Enforcement
1 Comment
UAEM Statement on Access to Non-Communicable Diseases Treatment
Here is a statement about access to affordable treatments for noncommunicable diseases prepared for the World Health Assembly’s committee session on NCDs last week by Health Action International and Universities Allied for Essential Medicines. Despite being submitted in due time … Continue reading
Civil Society’s letter on Conflicts of Interest, Future Financing, Reform and governance of the WHO
WHO Director General Margaret Chan presented the development plan – “The future of financing for WHO, World Health Organization: reforms for a healthy future” in 64th World Health Assembly held this month in Geneva. The plan is being greatly criticized … Continue reading
Posted in WHO
Leave a comment
Médecins Sans Frontières: EU position on AIDS response for UN summit at odds with support for WHO strategy
23 May 2011, Geneva “Today at the World Health Assembly, European countries, along with all World Health Organisation Member States, endorsed the WHO strategy for HIV/AIDS for the next five years, which sets ambitious goals and strategies to guide the health … Continue reading
Posted in HIV/Aids
Leave a comment
Money Needed for ART Funding
Inter Press Service, Tuesday, May 24, 2011 Louise Redvers JOHANNESBURG, May 23 (IPS) – Fixed targets for universal access to AIDS treatment and funding to make it achievable are what HIV and AIDS organisations want from the upcoming United Nations General … Continue reading
Posted in HIV/Aids
Leave a comment
Free trade: Bumpy road ahead on the way to a deal with Europe
Financial Times By Amy Kazmin Published: May 19 2011 17:32 For nearly four years, India and the European Union have been engaged in protracted and sometimes painful negotiations on a comprehensive free trade deal to apply to both goods and … Continue reading
Posted in EU-India FTA
Leave a comment
Developing countries tabled a proposal at WIPO on patent and public health
Bilateral and regional agreements should not restrict use of patent flexibilities at national level The African Group and the Development Agenda Group, which consists of some 20 cross-regional countries including Brazil, Egypt, India, Indonesia and South Africa put up a new … Continue reading
Posted in FTAs, TRIPS
Leave a comment
Civil Society on transparency, public health in TPPA: 28 Senators call for highest standards of protection IP in agreement
On Wednesday, May 18, 2011, eight civil society organizations submitted joint comments and recommendations on the Trans-Pacific Partnership Agreement [1] (TPPA). The document covers five broad areas including transparency, general public health safeguards, patent provisions, enforcement provisions, and pharmaceutical pricing … Continue reading
World’s poorest countries can improve access to medicines through local production, says United Nations
John Zarocostas, British Medical Journal Local production of pharmaceuticals in some poor African and Asian countries, such as Ethiopia, Uganda, and Bangladesh, has the potential to improve access to essential drugs for many of the one billion people who live … Continue reading
Posted in Uncategorized
Leave a comment
Clinton Health Access Initiative, UNITAID, and DFID Announce Lower Prices for HIV/AIDS Medicines in Developing Countries
Partnership to Reduce ARV Prices will Yield Savings of at Least $600 Million Over 3 Years Boston, MA; Geneva; and London, 17 May 2011 – Today, the Clinton Health Access Initiative (CHAI), UNITAID, and the UK’s Department for International Development (DFID) announced further price reductions … Continue reading
Posted in HIV/Aids
Leave a comment
